Clinical results support high intensity focused ultrasound (HIFU) for prostate tissue ablation after unsuccessful radiotherapy

Clinical results support high intensity focused ultrasound (HIFU) for prostate tissue ablation after unsuccessful radiotherapy
The global leader in therapeutic ultrasound, today announced the publication of a peer-reviewed article that analysed Ablatherm Robotic HIFU for prostate tissue ablation in patients who had previously undergone radiotherapy treatment. The article concludes that HIFU should be considered as a valuable therapeutic option for carefully selected patients who failed a previous radiotherapy treatment. The article has been published in the January 2017 edition of the prestigious peer-reviewed British Journal of Urology International.
DotMed